Liang Bai

76 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis.

Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis.

Journal: Metabolism: clinical and experimental

Published: July 03, 2026

Ultrasound-programmable adhesive hydrogel platform for sequential treatment of infected wounds.

Ultrasound-programmable adhesive hydrogel platform for sequential treatment of infected wounds.

Journal: Materials today. Bio

Published: March 31, 2026

Association between habitual dietary taurine intake and the risk of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.

Association between habitual dietary taurine intake and the risk of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.

Journal: Food & function

Published: February 25, 2026

Association between lactate-to-albumin ratio and 28-day mortality in critically ill patients with HFpEF: a retrospectively cohort study.

Association between lactate-to-albumin ratio and 28-day mortality in critically ill patients with HFpEF: a retrospectively cohort study.

Journal: Scientific reports

Published: October 22, 2025

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109.

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109.

Journal: The Journal of clinical investigation

Published: September 23, 2025

Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway.

Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway.

Journal: Journal of pharmaceutical analysis

Published: April 08, 2025

HDAC3 activates endothelial NLRP3 inflammasome and promotes atherosclerosis via inhibiting the acetylation of specificity protein 1.

HDAC3 activates endothelial NLRP3 inflammasome and promotes atherosclerosis via inhibiting the acetylation of specificity protein 1.

Journal: Cell death and differentiation

Published: March 31, 2025

Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms.

Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 11, 2025

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease.

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease.

Journal: Frontiers in medicine

Published: December 12, 2024

Emerging synergistic strategies for enhanced antibacterial sonodynamic therapy: Advances and prospects.

Emerging synergistic strategies for enhanced antibacterial sonodynamic therapy: Advances and prospects.

Journal: Ultrasonics sonochemistry

Published: October 23, 2024

miR-92a aggravates metabolic syndrome via KLF2/miR-483 axis.

miR-92a aggravates metabolic syndrome via KLF2/miR-483 axis.

Journal: Journal of diabetes investigation

Published: August 14, 2024

Kaempferol alleviates myocardial ischemia injury by reducing oxidative stress via the HDAC3-mediated Nrf2 signaling pathway.

Kaempferol alleviates myocardial ischemia injury by reducing oxidative stress via the HDAC3-mediated Nrf2 signaling pathway.

Journal: Journal of advanced research

Published: June 07, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026